NCT05032183 2025-08-11
Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Terminated
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute